Atai Life Sciences N.V.

In compliance with section 17(b) of the Securities Act, we are disclosing that Atai Life Sciences N.V. (NASDAQ: ATAI) is a client of TraDigital Marketing Group, Inc. Atai Life Sciences N.V. has a 9 month agreement in place, dated March 7, 2023 – December 21, 2023 to compensate TraDigital Marketing Group, Inc. a cash retainer of one hundred thirty thousand dollars ($130,000) paid as follows: one hundred thirty thousand dollars ($130,000), plus a monthly fee of 20% of the Marketing Cost Spent for publicly disseminating information about Atai Life Sciences N.V. via website, email, and SMS. 

Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. TraDigital Marketing Group, Inc., investor awareness and advisory services include multimedia marketing and other awareness services.